YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Parker Waichman Alonso LLP Headlines by Topic
Risperdal
Atypical Antipsychotics Linked to Worrisome Weight Gains, Other Outcomes, in Children
Oct 28, 2009 | Parker Waichman Alonso LLP
Yet another study has linked significant weight gains in children to some antipsychotic medication. Forbes reported that an emerging study found that...
Risperdal Said to be Responsible for Breast Growth in Boys
Jun 25, 2009 | Parker Waichman Alonso LLP
Risperdal has been linked to breast growth, and even lactation, in boys under 18 who take the powerful antipsychotic drug. The condition is...
Risperdal Researcher Promised Drug Maker Positive Results from Clinical Trials
Mar 20, 2009 | Parker Waichman Alonso LLP
A prominent Harvard psychiatrist promised positive results to Johnson & Johnson before the start of some clinical trials for Risperdal. ...
Misleading Risperdal, Duragesic Patch Claims Prompt Fines in West Virginia Lawsuit
Mar 4, 2009 | Parker Waichman Alonso LLP
Risperdal maker Johnson & Johnson has been ordered by a West Virginia judge to pay a hefty fine over a 2003 letter to doctors that obfuscated the...
Atypical Antipsychotic Drugs Double Heart Risks
Jan 15, 2009 | Parker Waichman Alonso, LLP
Atypical antipsychotic drugs, including Seroquel, Zyprexa and Risperdal, double the risk of heart failure and death, according to a new study...
Alzheimer's Patients on Risperdal, Thorazine, Other Anti-Psychotic Drugs, More Likely to Die
Jan 9, 2009 | Parker Waichman Alonso LLP
Using anti-psychotic drugs, such as Risperdal and Thorazine, to treat Alzheimer's disease patients isn't worth the increased risk of death, a new...
Doctor Agrees to Cut Drug Firm Ties
Jan 5, 2009 | Parker Waichman Alonso LLP
Dr. Joseph Biederman is the latest doctor whose activities with big pharmaceutical are under review. According to the Boston Globe’s...
Risperdal Promotion Questioned in Lawsuit
Nov 25, 2008 | Parker Waichman Alonso LLP
A prominent Harvard psychiatrist may have promised that his work at a psychiatric research institute would promote the off-label pediatric use...
Panel Questions Antipsychotics for Kids
Nov 20, 2008 | Parker Waichman Alonso LLP
Reuters is reporting that a panel of external experts is urging the U.S. Food and Drug Administration (FDA) and “other U.S. health...
American Children Take the Most Psychotropic Drugs
Sep 26, 2008 | Parker Waichman Alonso LLP
A new study reports that American children are about three times likelier to be prescribed psychotropic medications than children in Europe. ...
Risperdal
